Fibrous tubular conduit for stenting applications
US-2024189124-A1 · Jun 13, 2024 · US
US2016287415A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016287415-A1 |
| Application number | US-201615043968-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 15, 2016 |
| Priority date | Feb 13, 2012 |
| Publication date | Oct 6, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A device for treating a damaged tissue includes an expandable scaffold positionable in a portion of a luminal tissue structure of a mammal; and maintained via stent technology, wherein the scaffold is comprised of electrospun fibers composed of a biodegradable compound. The scaffold serves as a temporary template that allows the tissue to be rebuilt.
Opening claim text (preview).
1 - 30 . (canceled) 31 . A vascular tissue repair device, comprising: a generally tubular intraluminal scaffold having a luminal surface and an abluminal surface and being composed of nonwoven fibers made of a biodegradable and/or bioresorbable material, the luminal surface being comprised of substantially curvilinear nonwoven fibers and the abluminal surface comprising substantially linear fibers and the abluminal surface being adapted to face and be in apposition to a luminal wall of the vascular tissue; wherein the generally tubular intraluminal scaffold has an average porosity capable of cellular permeability. 32 . The vascular tissue repair device according to claim 31 , wherein the nonwoven fibers are made of poly(α-hydroxy esters). 33 . The vascular tissue repair device according to claim 31 , wherein the nonwoven fibers are made of polycaprolactone. 34 . The vascular tissue repair device according to claim 31 , wherein the generally tubular intraluminal scaffold further comprises elastin, collagen, DNA, RNA, glucosaminoglycans, polyhydroxyalkanoates or mixtures thereof. 35 . The vascular tissue repair device according to claim 31 , further comprising a stent. 36 . The vascular tissue repair device according to claim 35 , wherein the stent and the generally tubular intraluminal scaffold are diametrically expandable into apposition with the luminal wall of the vascular tissue. 37 . The vascular tissue repair device according to claim 31 , wherein the nonwoven fibers are electrospun fibers. 38 . The vascular tissue repair device according to claim 31 , wherein the nonwoven fibers are electrospun fibers and the stent is incorporated into the electrospun fibers. 39 . The vascular tissue repair device according to claim 31 , wherein the nonwoven fibers are treated with chemical agents, therapeutic agents or with gas plasma.
bioabsorbable · CPC title
Macromolecular materials · CPC title
Macromolecular materials · CPC title
Porous materials, e.g. foams or sponges · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.